Founded
31 Dec 1996
VCID: 390234
Profile
Corporate information
Official name
Point Biomedical Incorporated
Registration country
Official name
Point Biomedical Incorporated
Registration country
Investment activity status
Active investor
Company type
Developer of a microsphere that freely circulates when injected into the bloodstream.Funding
Funding rounds
(1 Jan 2008)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
CHL Medical Partners | Venture capital firm focused on early-stage healthcare sectors. | United States |
(1 Jan 2008)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
SR One Ltd | The venture capital unit of GlaxoSmithKline | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
CHL Medical Partners Venture capital firm focused on early-stage healthcare sectors. |
+1 (203) 324-7700 |
Series E |
|
De Novo Ventures |
+1 (650) 329-1999 |
Series E |
|
Invesco Private Capital (IPC) Inc |
+1 (720) 624-1904 |
Series E |
|
Saratoga Ventures LP |
+1 (650) 815-1942 |
N/A |
|
|
SR One Ltd The venture capital unit of GlaxoSmithKline |
+1 (610) 567-1000 |
Series E |